ReviewCurrent diabetes reports2015
Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now?
Review in Current diabetes reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2017Pooled it
- The p66International journal of molecular sciences · 2023Review
- Childhood diabetes mellitus and early-onset kidney diseases later in life: a nationwide population-based matched cohort study.BMC medicine · 2022Article
- Type 2 diabetes in youth: Rationale for use of off-label antidiabetic agents.Pediatric diabetes · 2022Article
- Type 2 Diabetes Mellitus in a 7 Year Old Girl.International medical case reports journal · 2022Article
- Youth-onset type 2 diabetes: translating epidemiology into clinical trials.Diabetologia · 2021Review
- Burden of Complications in U.S. Adults With Young-Onset Type 2 or Type 1 Diabetes.Diabetes care · 2020Article
- Prevalence of Diabetes and Its Determinants in the Young Adults Indian Population-Call for Yoga Intervention.Frontiers in endocrinology · 2020Article
- Impaired function of tendon-derived stem cells in experimental diabetes mellitus rat tendons: implications for cellular mechanism of diabetic tendon disorder.Stem cell research & therapy · 2019Article
- Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults with Type 2 Diabetes.Current diabetes reports · 2018Review
- Article
- Observational
- Article
- Change in life expectancy with type 2 diabetes: a study using claims data from lower Saxony, Germany.Population health metrics · 2017Article
- Hypertension and Diabetic Kidney Disease in Children and Adolescents.Diabetes spectrum : a publication of the American Diabetes Association · 2015Article
- Proportion of Brazilian diabetes patients that achieve treatment goals: implications for better quality of care.Diabetology & metabolic syndrome · 2015Article
- Biomarkers in Diabetic Retinopathy.The review of diabetic studies : RDSReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasingly, we recognise that type 2 diabetes in youth is a disease with an aggressive time course and a significant complication risk. On the other hand, outcomes for youth with type 1 diabetes appear generally to be improving. With increasing numbers of both types of diabetes in youth, it is timely that a comparative perspective is offered to help clinicians prognosticate more appropriately. Contemporary comparative studies add a new perspective to a consistent story, that for youth-onset type 2 diabetes, the development and progression of cardio-renal complications are increased and the survival prognosis is significantly worse than for type 1 diabetes. Here, we review this mounting evidence, highlight the importance of metabolic syndrome factors in the excess risk and underscore that there remains a significant mortality gap for youth with either type of diabetes, to be addressed as a matter of urgency.
Indexed as
Identifiers
25398205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.